NCT07053098 External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
| NCT ID | NCT07053098 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Maryland, Baltimore |
| Condition | Alcohol-Related Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-03-18 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-03-18 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.
Eligibility Criteria
Inclusion Criteria: * For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics. * For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder) * For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics. Exclusion Criteria: * For all: age is less than 18 years old * For all: not able to complete informed consent
Contact & Investigator
Melanie Bennett
PRINCIPAL INVESTIGATOR
University of Maryland, Baltimore
Frequently Asked Questions
Who can join the NCT07053098 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Alcohol-Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07053098 currently recruiting?
Yes, NCT07053098 is actively recruiting participants. Contact the research team at mbennett@som.umaryland.edu for enrollment information.
Where is the NCT07053098 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT07053098 clinical trial?
NCT07053098 is sponsored by University of Maryland, Baltimore. The principal investigator is Melanie Bennett at University of Maryland, Baltimore. The trial plans to enroll 40 participants.